Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 52 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
21 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Newton Biocapital Partners from Sint-Pieters-Woluwe, company number BE0673852565, closed financial year 2025 with a result of € -15,120 after tax. For that financial year Newton Biocapital Partners recorded a gross margin of € -8,515 and equity of € 36,300. Compared with financial year 2024, the result moved from € 28,818 to € -15,120. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2026.
€ 36,300
▼ 29% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -15,120
▼ still € 28,818 profit in 2024
Profit after tax over the fiscal year.
€ 67,205
▲ 51% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 30,100.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 182,461
▲ 18% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 304
▼ 99% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 72,907 | € -3,020 | € 60,628 | € -8,515 | ▼ € 69,143 |
| Profit after taxes | € 11,536 | € -27,210 | € 28,818 | € -15,120 | ▼ € 43,938 |
| Equity | € 49,813 | € 22,603 | € 51,420 | € 36,300 | ▼ 29% |
| Total debts | € 230,349 | € 216,529 | € 186,305 | € 204,311 | ▲ 10% |
| Cash | € 33,580 | € 28,923 | € 44,608 | € 67,205 | ▲ 51% |
| Retained profit | € 43,613 | € 16,403 | € 45,220 | € 30,100 | ▼ 33% |
| Balance sheet total | € 280,162 | € 239,132 | € 237,726 | € 240,611 | ▲ 1% |
Key figures of Newton Biocapital Partners, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Newton Biocapital Partners?
What happened at Newton Biocapital Partners in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 15,120 (▼ € 43,938 vs 2024). Source: NBB ↗
- HEYNEN CONSULTING AG became a director. NBB
- New establishment in Sint-Pieters-Woluwe. KBO
- A Q INVEST SRL became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 11,536 profit in 2022 to € 15,120 loss in 2025.
Paid € 58,046 in corporate taxes since 2022.
Best year ever: 2024, with € 28,818 profit.
A new publication or filing at Newton Biocapital Partners? We notify you, reason included.
Follow Newton Biocapital PartnersDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of A Q INVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Newton Biocapital PartnersBehind Newton Biocapital Partners are HEYNEN CONSULTING AG and A Q INVEST SRL. The shares are held by A Q INVEST (80%). It owns 100% of NEWTON BIOCAPITAL PARTNERS GODO KAISHA itself.
Directors
According to the 2025 annual accounts
Director · represented by Guillaume HEYNEN
Also active at: Newton Biocapital II Partners
since 2021
Director · represented by Alain PARTHOENS
Also active at: Ncardia Holding, Newton Biocapital I Investment Pool, DEXOWL, Newton Biocapital II Partners
since 2017
Shareholders
80%
Participations
NEWTON BIOCAPITAL PARTNERS GODO KAISHA
100%
Establishments
Establishment units
Physical locations of this company
Tervurenlaan 273
1150 Sint-Pieters-Woluwe
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 21 companies are registered at this address.
All companies at this address →BELGIAN RISK MANAGEMENT ASSOCIATION
European Coil Coating Association
€ 877,191 revenue · 2025
FEDERATION EUROPEENNE DE RISK MANAGEMENT - FEDERATION OF EUROPEAN RISK MANAGEMENT ASSOCIATIONS
€ 3.2 million revenue · 2024
LATOUR & PETIT
€ 1.5 million gross margin · 2025
AQ PARTNERS
€ 69,850 gross margin · 2025
+16 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0673.852.565
- VAT number
- BE 0673.852.565
- Registered office
- Tervurenlaan 273, 1150 Sint-Pieters-Woluwe
- Names & denominations
- Newton Biocapital Partners
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 April 2017
- Peppol
- Active · Active since 29 Jan 2026
- Activities · NACE
Overige financiële dienstverlening, neg
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering